Novozymes A/S (Chr. Hansen A/S)
Company Snapshot
Founded: 2024
Entity Type: Public
Employees: 11,000
Revenue: $4,702.3 Millions
Revenue Year: 2025
Segment: Planetary Health Biosolutions
Headquarter: Denmark
Key Geographics: North America, EMEA (Europe, Middle-east and Africa), Asia-Pacific, Latin America
Corporate Address: Biologiens Vej 2, 2800 Lyngby, Denmark Tel: +45-4446-0000 Web: www.novonesis.com
Company Overview
In January 2024, biotech company Novozymes A/S merged with Chr. Hansen to form Novonesis, whose bio-solutions portfolio includes enzyme products for the household detergents, bioenergy, food and beverage, agriculture (grain and technical processing), animal health, pharmaceuticals, and animal nutrition sectors. Its nutraceutical ingredients include natural botanicals, proteins, and vitamins. The company has a presence in more than 45 countries, with over 30 production facilities, serving more than 30 industries.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Novozymes A/S (Chr. Hansen A/S) In News
Company's Business Segments
- Food & Health Biosolutions : This segment offers enzymes and probiotic products that helps in determining the taste, texture, flavor, nutritional value, shelf life, and health benefits across numerious consumer products in the food and dairy industry.
- Planetary Health Biosolutions : This segment provides products for the dietary supplement, animal feed, infant formula, over-the-counter pharmaceutical, and plant protection industries.
Applications/End User Industries
- Food Industry
- Nutritional Industry
- Pharmaceutical Industry
- Agriculture Industry
- Life Sciences